Drug recall · June 15, 2022
Miocol-E recall
Why: cGMP deviations: Temperature abuse
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Miocol-E (acetylcholine chloride intraocular solution) 20 mg/2mL (10 mg/mL), Rx only, Manufacturer: Bausch & Lomb, NDC 24208-539-20
- Lots / codes
McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer. The letters clearly explain that consignees should identify product received from MMS between June 1 and September 30, 2021. A consignee should be able to use its own records to determine whether it received an impacted product from MMS during that timeframe and whether it still has any of that product in inventory. The recall notification letter informs consignees that they may contact Sedgwick if they have any questions.
- Quantity
- 45 kits
- Company
- Mckesson Medical-Surgical Inc. Corporate Office, Richmond, VA
- Distribution
- USA nationwide.
- Initiated
- April 13, 2022 · Voluntary: Firm initiated
- Classified
- June 9, 2022
- Reported
- June 15, 2022
- Ended
- November 30, 2023
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.